October, 27 2026 Tuesday 19:00 Hrs
Last update 11-9-2025
  • SENSEX :   73,598.67

  • Top commodity trading and broking companies in India-8.08( -0.01%) 27-Oct-2026
Negative
Sensex 73598.67 -8.08  (-0.01) 27-Oct-2026
Previous Day Close 73606.75
Today's High/Low
High Low
  •  
  •  
73762.98 73179.41

Company News Details

Morepen Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500288
INE083A01026
22.6801122
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MOREPENLAB
62.27
6926.13
EPS(TTM)
Face Value()
Div & Yield %
2.03
2
0.16
 

morepen laboratories ltd
Morepen Laboratories submits first ANDA to USFDA for Sitagliptin Tablets
Sep 28,2026
Morepen Laboratories has submitted its first Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration for Sitagliptin Tablets USP in 25 mg, 50 mg and 100 mg strengths. The submission extends the Company's established API and CDMO expertise into integrated finished dosage development and regulatory filing.

The Sitagliptin program brings together formulation development and scale-up, analytical method development and validation, impurity control, stability studies and manufacture of regulatory batches under GMP systems. It also incorporates bioequivalence strategy, coordination with contract research organizations and integration of development and study data into the regulatory dossier.

These capabilities strengthen Morepen's ability to support specialized CDMO assignments spanning API development, finished dosage formulation and regulatory submission, broadening the scope and complexity of customer programs it can undertake.

Morepen currently estimates 24–36 months from submission to progress towards approval and commercial supply, subject to FDA review, satisfactory completion of applicable formulation facility inspection requirements and applicable patent and exclusivity requirements.

Top

Attention Investor:

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.